Genetic Testing for Breast and Ovarian Cancer FAP and Lynch Syndrome - MEDICAID - LOUISIANA

Genetic testing for hereditary breast/ovarian cancer (BRCA1/2 and related panels), APC testing for familial adenomatous polyposis, and germline testing for Lynch syndrome is covered for individuals with qualifying personal or family histories—examples include early‑onset or multiple breast cancers, ovarian/pancreatic/male breast cancer, Ashkenazi Jewish ancestry, triple‑negative breast cancer ≤60 years, metastatic/intraductal or high‑grade prostate cancer, colorectal/uterine cancers with MSI‑H in patients <60, or other criteria listed (Amsterdam II/Revised Bethesda or predictive‑model thresholds). Coverage is limited to members who meet the specific clinical/family‑history criteria (including model‑based >5% BRCA probability where specified), is subject to age and relationship restrictions, requires exclusion of FAP for Lynch evaluations, and is governed by Louisiana Medicaid/LDH/MCO policy requirements.

"carcinoma of the small bowel"